Prior study has shown that Shikonin could inhibit the proinflammatory milieu generated at the early phase of colon cancer14, induce CRC cells apoptosis and autophagy through JNK signaling pathway15, and inhibit the metastatic progression in CRC via up-regulating the expression of SIRT216. This evidence concerns the gene MAPK8 and colorectal carcinoma.